
US Supreme Court rules unanimously in favor of Hikma, ending patent dispute with Amarin.
The US Supreme Court unanimously ruled in favor of Hikma Pharmaceuticals, ending a patent infringement lawsuit filed by Amarin. The dispute involved Hikma's generic icosapent ethyl, a fish oil-based medicine for severe hypertriglyceridemia, which Hik...



